Clinical Nutrition Market Growth Analysis and Industry Forecast, 2021-2028
Clinical nutrition product is a type of pharmaceutical product that helps to keep a patient healthy. It helps to improve the metabolic system by providing adequate supplements such as minerals, vitamins, and others. Clinical nutrition diagnosis and treat diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and help promote health through prevention of diet-related diseases. It works in both acute and ambulatory care settings, which includes cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.
Request for Sample Report@ https://www.alliedmarketresearch.com/request-sample/861
The growth of the global clinical nutrition market is majorly driven by rise in prevalence of metabolic disorders, high spending on healthcare, and the rise of the middle class in emerging economies. Further, the growing number of elderly population and development of clinical nutrition products specific to ageing population is expected to thrive the market growth. However, certain restraints such as lack of awareness for clinical medical nutrition and stringent regulations, are hampering the market growth for clinical nutrition.
By route of administration, the clinical nutrition market is segmented into oral, Enteral and Parental. Further, by application, it is divided into cancer, neurological disorders, metabolic disorders, gastrointestinal disorders and others. By end user, it is segregated into pediatric, adults, and geriatric. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America clinical nutrition market accounted for the largest share in 2020 followed by Europe; however, the Asia-Pacific region is anticipated to grow with the highest CAGR 7.20% during the forecast period.
North America accounted for the largest share in 2020, and is anticipated to maintain its dominance from 2021 to 2028, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure.
Key Benefits For Stakeholders
· This report entails a detailed quantitative analysis along with the current global clinical nutrition market trends from 2020 to 2028 to identify the prevailing opportunities along with the strategic assessment.
· The clinical nutrition market forecast is studied from 2021 to 2028.
· The market size and estimations are based on a comprehensive analysis of key developments in the clinical nutrition industry.
· A qualitative analysis based on innovative products facilitates strategic business planning.
· The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the clinical nutrition market.
Some of the key players operating in the global clinical nutrition market include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Lonza Ltd, Nestlé S.A., and Hero Nutritionals Inc.
